RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
| Cat.No. | Product name | Product Description |
| R10066 | Dapagliflozin; BMS512148 | Dapagliflozin is a potent and selective hSGLT2 inhibitor with EC50 of 1.1 nM, ex |
| R10123 | Bosetan | Bosentan is an endothelin (ET) receptor antagonist for ET-A and ET-B with Ki of |
| R10132 | Canagliflozin | Canagliflozin is a highly potent and selective SGLT2 inhibitor for hSGLT2 with I |
| R10185 | Otenabant Hydrochloride (CP 945598 Hydrochloride) | Otenabant (CP-945598) HCl is a potent and selective cannabinoid receptor CB1 ant |
| R10186 | CP945598 free base | Otenabant (CP945598) is a recently discovered selective, high affinity, competit |
| R10242 | AMG073 | Cinacalcet HCl represents a new class of compounds for the treatment of hyperpar |
| R10260 | Sotagliflozin; LP802034; LX4211 | LX-4211 is a potent dual SGLT2/1 inhibitor; Antidiabetic agents. |
| R10406 | AMD3465 hexahydrobromide (GENZ-644494 hexahydrobromide) | AMD 3465 6HBr(GENZ-644494) is a potent, selective CXCR4 antagonist; exhibits 8-f |
| R10436 | Ambrisentan; BSF208075; LU208075 | Ambrisentan is a highly selective antagonist of the endothelin-1 type A receptor |
| R10488 | Empagliflozin | Empagliflozin (BI-10773) is a potent and selective SGLT-2 inhibitor with IC50 of |
| R10489 | Canagliflozin hemihydrate | Canagliflozin 0.5 H2O(JNJ 28431754; TA 7284) is a highly potent and selective SG |
| R10491 | Ipragliflozin | Ipragliflozin (ASP1941) is a highly potent and selective SGLT2 inhibitor with IC |
| R10492 | Tofogliflozin | Tofogliflozin(CSG-452) hydrate is a potent and highly specific sodium/glucose co |
| R10543 | Plerixafor; AMD310 | Plerixafor (AMD3100) is a chemokine receptor antagonist for CXCR4 and CXCL12-med |
| R10609 | Reversine | Reversine is a potent human A3 adenosine receptor antagonist with Ki of 0.66 μM, |
| R10725 | CYM5442 | CYM 5442 HCl is a potent and selective EDG-1 (S1P1) agonist in vitro (EC50 = 1.3 |
| R10794 | Capadenoson; BAY 68-4986 | Capadenoson (BAY 68-4986) is a new adenosine A1 receptor agonist. |
| R10848 | Ki16198 | Ki16198 is the methyl ester of Ki16425, which is a LPA antagonist and inhibits L |
| R10950 | ozanimod;RPC1063;RPC-1063 | Ozanimod (RPC1063) is a selective oral S1P Receptor 1 modulator. Phase 3. |
| R10953 | ABC294640 | ABC294640 is an orally bioavailable and selective sphingosine kinase-2 (SphK2) i |
| R11455 | Plerixafor octahydrochloride; AMD3100 octahydrochloride; JM3100 octahydrochloride; SID791 octahydrochloride | Plerixafor 8HCl (AMD3100 8HCl) is the hydrochloride of Plerixafor, a chemokine r |
| R11505 | SQ22536 | SQ22536 is an inhibitor of adenylyl cyclase with an IC50 of 1.4 μM. It can inhib |
| R2032582 | BRL54443 | BRL 54443 is a potent 5-HT1E/1F receptor agonist (pKi values are 8.7 and 8.9 res |
